Nevro Current Ratio 2013-2024 | NVRO
Nevro current ratio from 2013 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Nevro Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2024-12-31 | $0.48B | $0.10B | 4.62 |
| 2024-09-30 | $0.48B | $0.10B | 5.02 |
| 2024-06-30 | $0.49B | $0.10B | 4.77 |
| 2024-03-31 | $0.49B | $0.07B | 7.38 |
| 2023-12-31 | $0.53B | $0.08B | 6.37 |
| 2023-09-30 | $0.52B | $0.08B | 6.55 |
| 2023-06-30 | $0.53B | $0.08B | 6.85 |
| 2023-03-31 | $0.54B | $0.08B | 7.15 |
| 2022-12-31 | $0.56B | $0.08B | 7.11 |
| 2022-09-30 | $0.57B | $0.08B | 7.05 |
| 2022-06-30 | $0.48B | $0.07B | 6.65 |
| 2022-03-31 | $0.49B | $0.07B | 6.97 |
| 2021-12-31 | $0.53B | $0.08B | 6.46 |
| 2021-09-30 | $0.54B | $0.08B | 7.20 |
| 2021-06-30 | $0.56B | $0.07B | 7.53 |
| 2021-03-31 | $0.74B | $0.25B | 3.00 |
| 2020-12-31 | $0.75B | $0.24B | 3.15 |
| 2020-09-30 | $0.74B | $0.24B | 3.10 |
| 2020-06-30 | $0.72B | $0.22B | 3.25 |
| 2020-03-31 | $0.41B | $0.06B | 6.79 |
| 2019-12-31 | $0.42B | $0.07B | 5.98 |
| 2019-09-30 | $0.40B | $0.07B | 5.87 |
| 2019-06-30 | $0.40B | $0.07B | 6.05 |
| 2019-03-31 | $0.41B | $0.07B | 6.30 |
| 2018-12-31 | $0.44B | $0.06B | 7.11 |
| 2018-09-30 | $0.43B | $0.05B | 8.05 |
| 2018-06-30 | $0.43B | $0.05B | 8.06 |
| 2018-03-31 | $0.43B | $0.05B | 7.99 |
| 2017-12-31 | $0.44B | $0.06B | 7.61 |
| 2017-09-30 | $0.43B | $0.05B | 8.78 |
| 2017-06-30 | $0.41B | $0.04B | 11.07 |
| 2017-03-31 | $0.41B | $0.03B | 11.91 |
| 2016-12-31 | $0.42B | $0.04B | 9.96 |
| 2016-09-30 | $0.41B | $0.04B | 11.83 |
| 2016-06-30 | $0.40B | $0.03B | 13.17 |
| 2016-03-31 | $0.27B | $0.03B | 10.49 |
| 2015-12-31 | $0.28B | $0.04B | 7.77 |
| 2015-09-30 | $0.28B | $0.02B | 11.88 |
| 2015-06-30 | $0.29B | $0.02B | 18.17 |
| 2015-03-31 | $0.19B | $0.01B | 13.98 |
| 2014-12-31 | $0.20B | $0.01B | 18.63 |
| 2014-09-30 | $0.05B | $0.01B | 6.16 |
| 2014-06-30 | $0.00B | 0.00 | |
| 2014-03-31 | $0.00B | 0.00 | |
| 2013-12-31 | $0.00B | 0.00 | |
| 2013-09-30 | $0.00B | 0.00 | |
| 2012-12-31 | $0.05B | $0.01B | 9.32 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.224B | $0.409B |
| Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $187.725B | 22.76 |
| Intuitive Surgical (ISRG) | United States | $176.405B | 80.93 |
| Alcon (ALC) | Switzerland | $46.824B | 31.12 |
| Edwards Lifesciences (EW) | United States | $42.608B | 27.66 |
| IDEXX Laboratories (IDXX) | United States | $34.032B | 39.36 |
| IQVIA Holdings (IQV) | United States | $31.084B | 17.20 |
| DexCom (DXCM) | United States | $26.777B | 41.39 |
| Mettler-Toledo (MTD) | United States | $24.611B | 28.69 |
| STERIS (STE) | Ireland | $22.269B | 25.47 |
| Waters (WAT) | United States | $21.897B | 31.05 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.380B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.612B | 14.91 |
| Hologic (HOLX) | United States | $13.861B | 14.96 |
| Sysmex ADR (SSMXY) | Japan | $11.941B | 37.44 |
| Penumbra (PEN) | United States | $10.300B | 93.17 |
| Globus Medical (GMED) | United States | $10.068B | 23.31 |
| Masimo (MASI) | United States | $9.002B | 37.78 |
| Teleflex (TFX) | United States | $6.407B | 9.86 |
| Glaukos (GKOS) | United States | $5.567B | 0.00 |
| Integer Holdings (ITGR) | United States | $3.967B | 22.27 |
| PROCEPT BioRobotics (PRCT) | United States | $3.194B | 0.00 |
| Veracyte (VCYT) | United States | $2.311B | 41.76 |
| TransMedics (TMDX) | United States | $2.265B | 66.61 |
| Nihon Kohden (NHNKY) | Japan | $2.205B | 12.06 |
| LivaNova (LIVN) | United Kingdom | $2.135B | 12.96 |
| Elekta AB (EKTAY) | Sweden | $1.995B | 17.93 |
| Integra LifeSciences Holdings (IART) | United States | $1.698B | 8.59 |
| Alphatec Holdings (ATEC) | United States | $1.462B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.274B | 0.00 |
| OPKO Health (OPK) | United States | $1.115B | 0.00 |
| Paragon 28 (FNA) | United States | $1.096B | 0.00 |
| Artivion (AORT) | United States | $1.034B | 98.32 |
| RxSight (RXST) | United States | $1.022B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.990B | 0.00 |
| AxoGen (AXGN) | United States | $0.820B | 0.00 |
| IRadimed (IRMD) | United States | $0.667B | 34.99 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.659B | 10.61 |
| Mesa Laboratories (MLAB) | United States | $0.645B | 14.09 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.636B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.598B | 0.00 |
| SiBone (SIBN) | United States | $0.596B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.531B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.525B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.425B | 0.00 |
| NeuroPace (NPCE) | United States | $0.400B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.380B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.351B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.347B | 7.37 |
| ClearPoint Neuro (CLPT) | United States | $0.329B | 0.00 |
| CVRx (CVRX) | United States | $0.318B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.313B | 16.73 |
| Inogen (INGN) | United States | $0.192B | 0.00 |
| Accuray (ARAY) | United States | $0.184B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.177B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| 908 Devices (MASS) | United States | $0.158B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.135B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.123B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.117B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.114B | 0.00 |
| Neuronetics (STIM) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | Israel | $0.080B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.078B | 11.82 |
| EDAP TMS S.A (EDAP) | France | $0.073B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.057B | 0.00 |
| Hyperfine (HYPR) | United States | $0.056B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.052B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.039B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Spectral AI (MDAI) | United States | $0.027B | 0.00 |
| Envoy Medical (COCH) | United States | $0.026B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| NexGel (NXGL) | United States | $0.023B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |